GSTM1 and anemia (phenotype): After excluding this study, the results suggested that iron sucrose and iron isomaltoside still resulted in comparable improvement in Hb for anemia (SMD=0; 95% CI=-0.16 to 0.16; P=0.44), and no heterogeneity remained (I2=0, P=0.87).